Download PDF
CC BY-NC-ND 4.0 · Indian J Med Paediatr Oncol 2020; 41(05): 770-772
DOI: 10.4103/ijmpo.ijmpo_116_20
Practitioner Section

A Case of Accidental Vincristine Overdose and Effective use of Therapeutic Plasma Exchange in Its Management

Hari Goyal
1   Department of Medical Oncology, Artemis Hospital, Gurugram, Haryana, India
,
Anil Khetarpal
2   Department of Blood Bank and Transfusion Medicine, Artemis Hospital, Gurugram, Haryana, India
,
Amit Jain
1   Department of Medical Oncology, Artemis Hospital, Gurugram, Haryana, India
› Author Affiliations Financial support and sponsorship Nil.
› Further Information
Also available at
   Permissions and Reprints

Abstract

Vincristine is a common drug used in hematological malignancy with a maximum per dose limited to 2 mg mainly to limit neurotoxicity. Vincristine overdose and wrong route of administration, though has been reported in world literature, but its appropriate management is still undefined. We report a case of Hodgkin lymphoma being treated with adriamycin, bleomycin, vinblastine and dacarbazine protocol, where vincristine was accidently administrated instead of vinblastine due to its “look-alike, sound-alike” nature. The patient developed severe toxicity due to the same, which was effectively managed by therapeutic plasma exchange.

Keywords

Look-alike - sound-alike drugs - medication error - overdose - therapeutic plasma exchange - vincristine


Publication History

Received: 30 March 2020

Accepted: 29 May 2020

Article published online:
17 May 2021

© 2020. Indian Society of Medical and Paediatric Oncology. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/.)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 

  • References

  • 1 Saha AS, Islam MF, Bhattacharya S, Giri PP. Clinical presentation of inadvertent intrathecal vincristine masquerading guillain-barre syndrome. Indian J Hematol Blood Transfus 2016; 32: 59-61
    CrossrefPubMedSearch in Google Scholar
  • 2 Chae L, Moon HS, Kim SC. Overdose of vincristine: Experience with a patient. J Korean Med Sci 1998; 13: 334-8
    CrossrefPubMedSearch in Google Scholar
  • 3 Kosmidis HV, Bouhoutsou DO, Varvoutsi MC, Papadatos J, Stefanidis CG, Vlachos P. et al. Vincristine overdose: Experience with 3 patients. Pediatr Hematol Oncol 1991; 8: 171-8
    CrossrefPubMedSearch in Google Scholar
  • 4 Schwartz J, Padmanabhan A, Aqui N, Balogun RA, Connelly-Smith L, Delaney M. et al. Guidelines on the use of therapeutic apheresis in clinical practice-evidence-based approach from the writing committee of the American Society for Apheresis: The Seventh Special Issue. J Clin Apheresis 2016; 31: 149-62
    CrossrefPubMedSearch in Google Scholar
  • 5 Ibrahim RB, Balogun RA. Medications and therapeutic apheresis procedures: Are we doing our best?. J Clin Apher 2013; 28: 73-7
    CrossrefPubMedSearch in Google Scholar
  • 6 Estlin EJ, Ronghe M, Burke GA, Yule SM. The clinical and cellular pharmacology of vincristine, corticosteroids, l-asparaginase, anthracyclines and cyclophosphamide in relation to childhood acute lymphoblastic leukaemia. Br J Haematol 2000; 110: 780-90
    CrossrefPubMedSearch in Google Scholar